Literature DB >> 6500693

Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.

S W Rothman, J E Brown, A Diecidue, D A Foret.   

Abstract

Toxin A and toxin B preparations of Clostridium difficile have been shown to affect metabolic functions of intact HeLa cells with different kinetics. The cytotoxins were purified from dialyzed filtrates of C. difficile strain VPI 10463 by hydrophobic interaction chromatography and ion-exchange chromatography and were concentrated by dialysis or by ultrafiltration. The toxins, which are immunologically unrelated, were analyzed by polyacrylamide gel electrophoresis and by immunochemistry with the Western blot technique. Toxin A was resolved into one major cytotoxic protein and a minor, rapidly migrating species that did not comigrate with toxin B. Toxin B was resolved into one major and three minor cytotoxic proteins. One protein comigrating with toxin A had no cytotoxic activity. The highly purified toxin A at 1.0 mg/ml caused loss of intracellular K+ and inhibition of protein synthesis in HeLa cells within 1 h. These effects correlated with morphological changes indicating cytotoxicity. At lower protein concentrations of toxin A (10- to 100-fold less), however, cytotoxic effects were seen at 120 min, whereas no changes in K+ levels or protein synthesis were yet evident. The toxin B preparation, 1,000-fold more toxic than toxin A, was diluted to equivalent cytotoxicity as measured in the overnight assay. Toxin B caused loss of K+ and inhibition of protein synthesis well after cytotoxic morphological changes were complete. In contrast, at higher protein concentrations (2- to 2,000-fold more), intracellular K+ was lost completely by 120 min. The effects on cell rounding and protein synthesis were incomplete at 120 min, but increased with the toxin B concentration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500693      PMCID: PMC261534          DOI: 10.1128/iai.46.2.324-331.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

2.  Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin.

Authors:  J E Brown; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

3.  Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin.

Authors:  I Florin; M Thelestam
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

4.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

5.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

6.  Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis.

Authors:  S W Rothman
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

7.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Comparison of two toxins produced by Clostridium difficile.

Authors:  N S Taylor; G M Thorne; J G Bartlett
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture.

Authors:  M Thelestam; M Brönnegård
Journal:  Scand J Infect Dis Suppl       Date:  1980

10.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

View more
  16 in total

Review 1.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

2.  Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.

Authors:  S P Borriello; F E Barclay; P J Reed; A R Welch; J D Brown; D W Burdon
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

3.  Effect of Clostridium difficile enterotoxin A on ultrastructure of Chinese hamster ovary cells.

Authors:  V M Kushnaryov; J J Sedmak
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

4.  GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis.

Authors:  C B Kurtz; E P Cannon; A Brezzani; M Pitruzzello; C Dinardo; E Rinard; D W Acheson; R Fitzpatrick; P Kelly; K Shackett; A T Papoulis; P J Goddard; R H Barker; G P Palace; J D Klinger
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.

Authors:  Nicola L Davies; Joanne E Compson; Brendon Mackenzie; Victoria L O'Dowd; Amanda K F Oxbrow; James T Heads; Alison Turner; Kaushik Sarkar; Sarah L Dugdale; Mark Jairaj; Louis Christodoulou; David E O Knight; Amanda S Cross; Karine J M Hervé; Kerry L Tyson; Hanna Hailu; Carl B Doyle; Mark Ellis; Marco Kriek; Matthew Cox; Matthew J T Page; Adrian R Moore; Daniel J Lightwood; David P Humphreys
Journal:  Clin Vaccine Immunol       Date:  2013-01-16

6.  A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.

Authors:  Jennifer Peppe; Andrew Porzio; David M Davidson
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

7.  Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.

Authors:  D C Dailey; A Kaiser; R H Schloemer
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

8.  Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

Authors:  R Eglow; C Pothoulakis; S Itzkowitz; E J Israel; C J O'Keane; D Gong; N Gao; Y L Xu; W A Walker; J T LaMont
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

Authors:  W A Flegel; F Müller; W Däubener; H G Fischer; U Hadding; H Northoff
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.

Authors:  C Pothoulakis; J T LaMont; R Eglow; N Gao; J B Rubins; T C Theoharides; B F Dickey
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.